Moreover, the varied alterations in PTX3 and adropin, as inflammatory markers, indicate their potential to predict renal injury in diabetic patients to differing extents and their association with the development of diabetic kidney disease [42]. This evidence concerns the gene PTX3 and diabetic kidney disease.